MVA85A (Tuberculosis vaccine)
Sponsors
University of Oxford
Conditions
Tuberculosis
Phase 1
A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
CompletedNCT00423839
Start: 2003-03-31End: 2005-07-31Target: 12Updated: 2007-01-18
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.
CompletedNCT00423566
Start: 2002-09-30End: 2003-07-31Target: 14Updated: 2007-01-18